Overview

Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

Status:
Completed
Trial end date:
2019-12-20
Target enrollment:
Participant gender:
Summary
To Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg
Phase:
Phase 4
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical